The Safety of Plasma-Derived versus Recombinant Concentrates
In this monograph, the author offers his perspective on the risk of infection from recombinant and plasma-derived products.
Transmissible Agents and the Safety of Coagulation Factor Concentrates
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian A multifaceted approach that includes safety measures at every stage of production is needed to minimize the risk of viral transmission by coagulation factor replacement products.
Small Pool Heat-Treated Intermediate Purity Factor VIII Concentrate
Small pool heat-treated intermediate purity concentrate may be the most suitable and cost-effective solution for some countries attempting sufficiency and who cannot afford high-purity products.
The Preparation of Single Donor Cryoprecipitate
This monograph provides guidelines for the production of single-donor cryoprecipitate.
The Treatment of Hemophilia Bleeding with Limited Resources
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian Treatment for bleeding in hemophilia involves replacement therapy of the missing coagulation factor, but adequate replacement therapy is not always available. This monograph describes conservative measures that decrease or control bleeding and help prevent future damage.
Economic Benefits of Basic Hemophilia Treatment & Care – Japanese
Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese このファクトシートには、血友病患者に基本的な治療およびケアを提供するメリットが記載されています。適切なケアには、血友病治療センターおよび治療用製剤の利用、医療関係者、患者、家族に対する教育が含まれます。
Benefits of Treating Hemophilia with Factor Concentrate – Japanese
Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese 安全で規制を順守している血漿由来凝固因子濃縮製剤で血友病患者を治療することは、出血性疾患患者への社会経済的影響、さらには政府やコミュニティ、家族から求められる長期的支援を直接軽減します。
Proceedings of the WFH’s Third Global Forum on the Safety and Supply of Hemophilia Treatment Products
A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia Treatment Products, which brings together patient groups, healthcare providers, regulators, industry representatives, and not-for-profit fractionators.
Looking After the Veins
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Farsi A description of the correct procedures for venipuncture to avoid vein damage.
Looking After the Veins – Farsi
Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for […]
Delivery of Treatment for Haemophilia: Report of a Joint WHO/WFH/ISTH Meeting
Helps identify effective treatment strategies for hemophilia. Topics include delivery of treatment, on-demand treatment, prophylaxis, immune tolerance, and factor assays.
Improving Care Beyond our Borders: A Twinning Guide for Hemophilia Treatment Centres
The Hemophilia Treatment Centre (HTC) Twinning program pairs emerging HTCs with established ones to help increase the levels of diagnosis and medical attention for people with hemophilia.